ea0063gp185 | Benign Thyroid Disorders | ECE2019
Sbardella Emilia
, Tenuta Marta
, Sirgiovanni Grazia
, Pozza Carlotta
, Gianfrilli Daniele
, Mazzotta Paola
, Pandozzi Carla
, Cortesi Enrico
, Lenzi Andrea
, Gelibter Alain J
, Isidori Andrea M
Introduction: Immune-Checkpoint Inhibitors (ICI) are frequently associated with thyroid-related adverse events (AE). Several studies analyzed thyroid disfunctions during ICI therapy, but many aspects remain to be characterized, especially for the most recent anti-PD-1 drugs. The aim of this study is to determine incidence and characteristics of PD-1 inhibitors associated thyroid dysfunction.Methods: We retrospectively analyzed data of patients with advan...